Technical Specifications Compound: Semaglutide Quantity: 30 mg Format: Lyophilized powder Type: Synthetic peptide Structure: Modified peptide sequence Purity: Research-grade Intended use: Laboratory research only Shipping & Fulfillment Orders are processed through our controlled fulfillment workflow and shipped securely from our U.S
Pharmacological properties: Semaglutide is an insulin-like peptide-1 receptor agonist whose main pharmacological action is to mimic the action of GLP-1 produced in the body
Trademark Notice
Product documentation may include identity, purity, and related analytical reference information depending on batch and product format
These risks and uncertainties include, but are not limited to, those factors described in the Risk Factors section of each of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and any of our subsequent filings with the Securities and Exchange Commission (the Commission)
Similar content being viewed by others Introduction Aging is the primary driver of chronic diseases, multimorbidity, and mortality worldwide, positioning interventions targeting biological aging as promising therapeutic strategies with potential to substantially improve human healthspan 1,2
